Sabbah, M.;                     Najem, A.;                     Krayem, M.;                     Awada, A.;                     Journe, F.;                     Ghanem, G.E.    
        RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers 2021, 13, 1685.
    https://doi.org/10.3390/cancers13071685
    AMA Style
    
                                Sabbah M,                                 Najem A,                                 Krayem M,                                 Awada A,                                 Journe F,                                 Ghanem GE.        
                RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers. 2021; 13(7):1685.
        https://doi.org/10.3390/cancers13071685
    
    Chicago/Turabian Style
    
                                Sabbah, Malak,                                 Ahmad Najem,                                 Mohammad Krayem,                                 Ahmad Awada,                                 Fabrice Journe,                                 and Ghanem E. Ghanem.        
                2021. "RTK Inhibitors in Melanoma: From Bench to Bedside" Cancers 13, no. 7: 1685.
        https://doi.org/10.3390/cancers13071685
    
    APA Style
    
                                Sabbah, M.,                                 Najem, A.,                                 Krayem, M.,                                 Awada, A.,                                 Journe, F.,                                 & Ghanem, G. E.        
        
        (2021). RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers, 13(7), 1685.
        https://doi.org/10.3390/cancers13071685